Candidemia in Cancer Patients: A Prospective, Multicenter Surveillance Study by the Invasive Fungal Infection Group (IFIG) of the European Organization for Research and Treatment of Cancer (EORTC)
The DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
In a surveillance study of candidemia in cancer patients that was conducted by the European Organization for Research and Treatment of Cancer, 249 episodes were noted; Candida albicans was isolated in 70% (63) of the 90 cases involving patients with solid tumors (tumor patients) and in 36% (58) of the 159 involving those with hematologic disease (hematology patients). Neutropenia in tumor patients and acute leukemia and antifungal prophylaxis in hematology patients were significantly associated with non-albicans candidemia in a multivariate analysis. Overall 30-day mortality was 39% (97 of 249). In a univariate analysis, Candida glabrata was associated with the highest mortality rate (odds ratio, 2.66). Two multivariate analyses showed that mortality was associated with older age and severity of the underlying disease. Among hematology patients, additional factors associated with mortality were allogeneic bone marrow transplantation, septic shock, and lack of antifungal prophylaxis.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Previous studies also showed a significant association between receipt of antifungal prophylaxis as well as acute leukemia and a higher incidence of candidemia caused by Candida species other than C. albicans (41).”
In the citing paper
“In cancer patients, Viscoli et al. [18] also suggested that C. glabrata was associated with a higher mortality rate.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [18]
In the citing paper
“Other North American and European investigators confirmed these observations in larger hospital settings [10, 11, 13, 20, 22, 25, 26].”
From Epidemiology of Candidemia in Swiss Tertiary Care Hospitals: Secular Trends, 1991–2000 (2004) · cites this paper as [11]
In the citing paper
“Candidemia due to C. parapsilosis has increased in frequency in pediatric populations and appears to be associated with a lower mortality rate than is candidemia due to other species of Candida [110-113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
In the citing paper
“Candidemia due to C. glabrata may be associated with increased mortality in patients with cancer [113].”
From Guidelines for Treatment of Candidiasis (2004) · cites this paper as [113]
Citations
Cites
Regression Models and Life-Tables
Cox, D. R. (1992) · Springer Series in Statistics · doi:10.1007/978-1-4612-4380-9_37 · Cited by 26,297
(2008) · The Concise Encyclopedia of Statistics · doi:10.1007/978-0-387-32833-1_5 · Cited by 2,670
Goodman, J. L., Winston, D. J., Greenfield, R. A., Chandrasekar, P. H., Fox, B., Kaizer, H., Shadduck, R. K., Shea, T. C., Stiff, P., Friedman, D. J., et al. (1992) · New England Journal of Medicine · doi:10.1056/nejm199203263261301 · Cited by 1,174 · cited 1×
“However, this phenomenon has not been confirmed in large prospective studies [26-29].”
ResultSecular Trends in the Epidemiology of Nosocomial Fungal Infections in the United States, 1980-1990
Sague, C. M. B., Jarvis, W. R., & System, N. N. I. S. (1993) · Journal of Infectious Diseases · doi:10.1093/infdis/167.5.1247 · Cited by 1,140
Rex, J. H., Bennett, J. E., Sugar, A. M., Pappas, P. G., van der Horst, C. M., Edwards, J. E., Washburn, R. G., Scheld, W. M., Karchmer, A. W., Dine, A. P., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199411173312001 · Cited by 1,039
Wingard, J. R., Merz, W. G., Rinaldi, M. G., Johnson, T. R., Karp, J. E., & Saral, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199110313251803 · Cited by 937 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
Resistance of Candida species to fluconazole
Rex, J. H., Rinaldi, M. G., & Pfaller, M. A. (1995) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.39.1.1 · Cited by 877 · cited 1×
“glabrata) in patients receiving fluconazole [23-25].”
The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistance
Hong Nguyen, M., Peacock, J. E., Morris, A. J., Tanner, D. C., Nguyen, M. L., Snydman, D. R., Wagener, M. M., Rinaldi, M. G., & Yu, V. L. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(95)00010-0 · Cited by 758 · cited 1×
“given about the patients' predisposing conditions [15].”
Survival Analysis: A Practical Approach.
Smith, P. J., Parmar, M. K. B., & David, M. (1996) · Journal of the American Statistical Association · doi:10.2307/2291609 · Cited by 730
Candidemia in a tertiary care hospital: epidemiology, risk factors, and predictors of mortality.
Fraser, V. J., Jones, M., Dunkel, J., Storfer, S., Medoff, G., & Dunagan, W. C. (1992) · Clinical Infectious Diseases · doi:10.1093/clind/15.3.414 · Cited by 679 · cited 2×
“glabrata [3, 4, 1522].”
Background
Cited by
Items 501–600 of 647
Belgacem, S., Chebil, W., Salem, S. B., Babba, O., Mastouri, M., & Babba, H. (2024) · Medical Mycology · doi:10.1093/mmy/myae070 · Cited by 3
DESCRITORES MORFOLÓGICOS DA FOLHA EM ACESSOS DE CASTANHEIRA-DO-BRASIL
do Nascimento, W. M. O., Salgado, C. M., & de Souza, O. T. (2023) · doi:10.22533/at.ed.3212324042 · Cited by 3
Clinical Experience of Anidulafungin for the Treatment of Patients with Documented Candidemia
Falcone, M., Russo, A., Rosa, F. G. D., Pasero, D., Toma, L., Raponi, G., Ghezzi, M. C., & Venditti, M. (2010) · Journal of Chemotherapy · doi:10.1179/joc.2010.22.6.397 · Cited by 3
Primer caso de infección fúngica invasora por Candida fabianii en un paciente pediátrico no neonatal
Flores-González, J. C., Guerrero-Lozano, I., Perez-Guerrero, J., Hernández-González, A., Galán‐Sánchez, F., Quintero-Otero, S., Quiñones, F. R., & Pantoja-Rosso, S. (2015) · Revista Iberoamericana de Micología · doi:10.1016/j.riam.2015.06.003 · Cited by 3
In vitro evaluation of vincristine and fluconazole combination against Candida.
Khan, A. A., Khurshid, M., & Tawfik, A. F. (2013) · PubMed · Cited by 3
Kanesaka, I., Kanayama, A. K., Takamitsu, I. T. O. U., Uchino, U., KOYAMA, H., Matsuzaki, K., Matsumoto, S., & Kobayashi, I. (2016) · Kansenshogaku zasshi · doi:10.11150/kansenshogakuzasshi.90.787 · Cited by 3
Albakri, A. (2019) · Research and Review Insights · doi:10.15761/rri.1000151 · Cited by 3
“Corticosteroids, antineoplastic or antibiotic are also important risk factors [13,142,148].”
BackgroundMethodInfluentialIn VitroActivity of Fluconazole, Voriconazole and Caspofungin against Clinical Yeast Isolates
Maida, C. M., Milici, M. E., & Oliveri, S. M. (2007) · Journal of Chemotherapy · doi:10.1179/joc.2007.19.3.277 · Cited by 3
Detection of Candida albicans from Positive Blood Culture Bottles
Saad, U., Siddiqui, S., Jamil, N., Jamil, S., & Hafiz, S. (2013) · International Journal of Pathology · Cited by 3
[Invasive mycosis, immunocompromise and fever of unknown origin].
Méndez‐Tovar, L. J., Manzano–Gayosso, P., Cumplido-Uribe, C., Hernández, F. H., Ramos-Hernández, J. M., & López‐Martínez, R. (2012) · PubMed · Cited by 3
Thérapeutique des mycoses profondes (à l'exception des aspergilloses et des fusarioses)
Leautez, S., & Raffi, F. (2001) · Revue Française des Laboratoires · doi:10.1016/s0338-9898(01)80124-4 · Cited by 3
Immunomodulators: Potential in Treatment of Systemic Fungal Infections
Zia, Q., Fatima, N., Alam, M., Bisht, D., Yadav, P., Ahmad, I., Aqil, F., & Owais, M. (2010) · Springer eBooks · doi:10.1007/978-3-642-12173-9_17 · Cited by 3
Les candidoses buccales: revue de littérature
Born, F. (2013) · Archive ouverte UNIGE (University of Geneva) · doi:10.13097/archive-ouverte/unige:27981 · Cited by 3
Pasqualotto, A. C. (2004) · Americanae (AECID Library) · Cited by 3
Cantürk, Z. (2016) · MARMARA PHARMACEUTCAL JOURNAL · doi:10.12991/mpj.20162008960 · Cited by 2
“Candida is the most important yeast that affects humans and causes opportunistic infections especially in immunocompromised patients, worldwide (1).”
BackgroundGiordano, A., Landro, F. D., Carolis, E. D., Criscuolo, M., Dragonetti, G., Fianchi, L., & Pagano, L. (2021) · Journal of Fungi · doi:10.3390/jof7090778 · Cited by 2
“The incidence of proven or probable mold and yeast infections can reach 24% among patients with leukemia [3].”
BackgroundSilvestri, F. F., Bassetti, M., Zaramella, M., Domenis, L., Piazza, V. D., Fazio, M., Maschio, M., Moretti, V., & FADOI-FVG, F. (2014) · Italian Journal of Medicine · doi:10.4081/itjm.2014.481 · Cited by 2
Tratamiento actual de la candidemia. Papel de anidulafungina
Almirante, B., & Pemán, J. (2008) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/s0213-005x(08)76589-3 · Cited by 2
Molecular modeling of the Candida albicans Vps4 and a virtual screening study for novel inhibitors
Chen, H., Yu, H., Huang, H., Li, W., & Yang, D. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-012-0460-9 · Cited by 2
“Studies have shown that the deletion of Vps4 is sufficient to abolish the pathogenicity of Candida albicans.”
BackgroundAntifungal Therapy for Invasive Fungal Infections
Badali, H., Khodavaisy, S., Davoudi, M. M., Biranvand, E., & Mardani, M. (2014) · Majallah-i dānishgāh-i ̒ulūm-i pizishkī-i Māzandarān/Journal of Mazandaran University of Medical Sciences · Cited by 2
Ardura, M. I., & Koh, A. Y. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-40181-4.00097-9 · Cited by 2
Oropharyngeal candidiasis in children with lymphohematopoietic malignancies in Mashhad, Iran
Berenji, F., Zabolinejad, N., Badiei, Z., Kakhi, S., Aliabadi, Z. A., & Ganjbakhsh, M. (2015) · Current Medical Mycology · doi:10.18869/acadpub.cmm.1.4.33 · Cited by 2
Design, Synthesis and Molecular Docking Study of substituted N-aminocarbonyl arylvinylbenzamides
Bari, S. B., Haswani, N. G., Patel, H., & Patel, R. (2013) · Cited by 2
Recent Developments in Epidemiology and Management of Invasive Fungal Infections
Groll, A. H., & Walsh, T. J. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-333-0_14 · Cited by 2
The Impact of Antifungal Drug Resistance in the Clinic
Lewis, R. E., & Kontoyiannis, D. P. (2014) · ASM Press eBooks · doi:10.1128/9781555817176.ch23 · Cited by 2
[Risk factors associated with multiple-species candidemia].
Benetucci, A., Tiraboschi, I. N., Fernández, N., Perazzi, B. E., & Lasala, M. B. (2008) · PubMed · Cited by 2
Systemmykosen: Risiko Immunsuppression
Ruhnke, M. (2003) · Pharmazie in unserer Zeit · doi:10.1002/pauz.200390026 · Cited by 2
[Drug of the month. Voriconazole (Vfend)].
Piérard, G. E., Arrese, J. E., Quatresooz, P., & Piérard-Franchimont, C. (2003) · PubMed · Cited by 2
Seghir, A., Boucherit‐Otmani, Z., Boucherit, K., & Sari-Belkharroubi, L. (2017) · Journal de Mycologie Médicale · doi:10.1016/j.mycmed.2017.10.002 · Cited by 2
Colonisation of acrylic denture fitting surfaces by Candida species
Knight, N. J. (2014) · Otago University Research Archive (University of Otago) · Cited by 2
Epidemiology of Candidemia in Finland
Poikonen, E. (2011) · Helda - University of Helsinki Institutional Repository · Cited by 2
Antifungal Drug Discovery: Old Drugs, New Tools
Backer, M. D. D., Luyten, W. H. M. L., & Bossche, H. F. A. V. (2002) · Humana Press eBooks · doi:10.1007/978-1-59259-172-5_12 · Cited by 2
Savage, H. P., Bays, D. J., Gonzalez, M. A. F., Bejarano, E. J., Nguyen, H., Masson, H. L. P., de Carvalho, T. P., Santos, R. L., Thompson, G. R., & Bäumler, A. J. (2023) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2023.04.17.537218 · Cited by 2
Antifungal Prophylaxis In Hematopoietic Stem Cell Transplant Recipients
Stojanoski, Z., Pivkova-Veljanovska, A., Genadieva-Stavrik, S. G., Cevreska, L. A., Petrovska, M., & Georgievski, B. (2008) · Macedonian Journal of Medical Sciences · doi:10.3889/mjms.1857-5773.2008.0002 · Cited by 1
Wade, J. C. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3764-2_52 · Cited by 1
Hunter, C. J., Chou, A. D., Roeder, H., Eighmy, W., Bewersdorf, J. P., Mendez, L., Stahl, M. F., Podoltsev, N. A., Zeidan, A. M., & Shallis, R. M. (2025) · Leukemia Research · doi:10.1016/j.leukres.2025.108144 · Cited by 1
Norkin, M. N., & John, R. (2011) · InTech eBooks · doi:10.5772/22537 · Cited by 1
“glabrata [125-126] make the echinocandins preferable choices for the initial treatment of IC in patients with AL and HCT recipients.”
BackgroundCandida Colonization Index in the Management of Critically III Patients
Eggimann, P., & Pittet, D. (2007) · Springer eBooks · doi:10.1007/0-387-35096-9_56 · Cited by 1
Prophylactic Vaccination of Cancer Patients and Hematopoietic Stem Cell Transplant Recipients
Decker, W. K., & Safdar, A. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_50 · Cited by 1
Antifungal Therapy in the Intensive Care Unit
Paiva, J. A., & Pereira, J. M. (2007) · Springer eBooks · doi:10.1007/978-3-540-34406-3_11 · Cited by 1
Infektionen bei malignen Erkrankungen
Maschmeyer, G. (2009) · Springer eBooks · doi:10.1007/978-3-540-79725-8_38 · Cited by 1
Chapman, S. W. (2007) · Current Infectious Disease Reports · doi:10.1007/s11908-007-0068-2 · Cited by 1
Antifungal tedavide son gelişmeler
Kaan, K. (2008) · Ankara Universitesi Eczacilik Fakultesi Dergisi · doi:10.1501/eczfak_0000000491 · Cited by 1
Early versus Late Fluconazole Prophylaxis in Autologous Hematopoietic Cell Transplantation
Guaraná, M., Nucci, M., Barreiros, G., Valeri, J., Almeida, C., & Nouér, S. A. (2021) · Transplantation and Cellular Therapy · doi:10.1016/j.jtct.2021.04.019 · Cited by 1
Antifungal Prophylaxis and Therapy: Controversies and Emerging Issues
Dominguez, E. A. (2001) · Perspectives on critical care infectious diseases · doi:10.1007/978-1-4615-1403-9_11 · Cited by 1
Kim, S., Lee, D., Choi, S., Kwon, J., Park, S. H., Choi, J., Yoo, J., Lee, S., Cho, B., Kim, Y., et al. (2010) · Infection and Chemotherapy · doi:10.3947/ic.2010.42.3.149 · Cited by 1
Fungaemia in elderly patients☆
Krcmery, V., Jurga, L., Mateička, F., & Šulcová, M. (2001) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(01)00300-4 · Cited by 1
Self-citationInfectionsgraves chez l'immunodéprimé en oncohématologie
Blot, F., Nitenberg, G., & Leclercq, B. (2004) · EMC-Anesthésie réanimation/Encyclopédie médico-chirurgicale. Anesthésie, réanimation · doi:10.1016/s0246-0289(01)00037-8 · Cited by 1
Franco, M. P., Green, J. S., & Young, J. H. (2017) · Springer eBooks · doi:10.1007/978-3-319-64263-5_50 · Cited by 1
Hemsley, C. J., & Kibbler, C. (2009) · Elsevier eBooks · doi:10.1016/b978-0-443-10147-2.50047-3 · Cited by 1
Hematology Unit, A. O. C., Vigna, E., Caracciolo, D., Hematology Unit, A. O. C., Perugini, D., Hematology Unit, A. O. C., Martino, E. A., Hematology Unit, A. O. C., Mendicino, F., Hematology Unit, A. O. C., et al. (2022) · Journal of Clinical Images and Medical Case Reports · doi:10.52768/2766-7820/1581 · Cited by 1
“Invasive Geotrichum capitatum infection is relatively rare, as approximately 100 cases have been reported in patients with hematological malignancies [2,8-11].”
BackgroundYaman, M., Özhak, B., & Mutlu, G. (2023) · Medical Science and Discovery · doi:10.36472/msd.v10i2.868 · Cited by 1
“%) among a total of 249 cancer patients with candidemia, of which 90 had solid tumors and 159 had hematological malignancies (19).”
BackgroundAntifungal Therapy in Patients with Hematological Malignancies
Herbrecht, R., & Nivoix, Y. (2010) · Springer eBooks · doi:10.1007/978-3-642-15742-4_44 · Cited by 1
“In general, response rates were low, and over 40% of the patients with invasive candidiasis or invasive aspergillosis treated with amphotericin B died [56, 73, 119].”
BackgroundModulation of inflammation by genetic variation in innate immunity
Plantinga, T. S. (2012) · Radboud Repository (Radboud University) · Cited by 1
Brakhage, A. A., & Zipfel, P. F. (2014) · ASM Press eBooks · doi:10.1128/9781555816872.ch13 · Cited by 1
Infections in Neutropenic Hosts
Rosser, S. J., & Bow, E. J. (2009) · Wiley eBooks · doi:10.1002/9781444301601.ch15 · Cited by 1
La terapia antifungina empirica in oncoematologia: criteri di scelta
Girmenia, C. (2006) · Hematology Meeting Reports (formerly Haematologica Reports) · doi:10.4081/hmr.v2i2.781 · Cited by 1
Self-citationDynamics of Microeukaryotes and Archaea in the Mammalian Gut Microbiome
Dollive, S. (2013) · Scholarly Commons (University of Pennsylvania) · Cited by 1
Management of Resistant Candida Infections
Clements, S., & Kibbler, C. C. (2004) · Humana Press eBooks · doi:10.1007/978-1-59259-738-3_16 · Cited by 1
Criterios diagnósticos y actitudes terapéuticas en las fungemias
Pahissa, A. (2001) · Revista Clínica Española · doi:10.1016/s0014-2565(01)70808-9 · Cited by 1
Nosocomial Candidemia in Geriatric Patients
Kovacicova, G., & Krcmery, V. (2001) · Journal of Chemotherapy · doi:10.1179/joc.2001.13.3.340 · Cited by 1
Self-citationde la Rubia, J., García, I., & Jarque, I. (2000) · Cited by 1
Infections in the neutropenic cancer patient
Marchetti, O., & Calandra, T. (2010) · Elsevier eBooks · doi:10.1016/b978-0-323-04579-7.00073-3 · Cited by 1
Mecanismos de resistencia a azoles en especies de candida no-albicans
Navarro-Rodríguez, P. (2019) · Rovira & Virgili repository · Cited by 1
Levaduras del género Candida de procedencia clínica: Evaluación de métodos de identificación
Perera, C., & Delia, C. (2000) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) · Cited by 1
Non- albicans Candida Infections
Sobel, J. D., & Revankar, S. G. (2014) · ASM Press eBooks · doi:10.1128/9781555815592.ch19
Lotz, H. (2004) · OPUS Publication Server of the University of Stuttgart (University of Stuttgart) · doi:10.18419/opus-1644
Three major achievements of the Infections Disease Group
Bassetti, M., Cordonnier, C., Maertens, J. A., Marchetti, O., Paesmans, M., Pylkkänen, L. H., Verweij, P. E., & Donnelly, J. P. (2012) · European Journal of Cancer Supplements · doi:10.1016/s1359-6349(12)70016-2
Magri, M. M. C. (2012) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.5.2012.tde-07022013-115954
Anti-Fungal Therapy in the ICU
Paiva, J.-A. (2001) · Springer eBooks · doi:10.1007/978-1-4615-1679-8_10
Rapid And Reliable Detection Of Fungemia By Polymerase Chain Reaction
Tirodker, U., Nataro, J. P., & Fairchild, K. D. (2004) · Springer eBooks · doi:10.1007/978-3-642-18480-2_19
Kantarcıoğlu, A. S., & YÜCEL, A. (2014) · DergiPark
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment
Bassetti, M., & Mikulska, M. (2011) · Springer eBooks · doi:10.1007/978-3-642-03519-7_11
Infecciones graves en pacientes inmunodeprimidos en oncohematología
Blot, F., Leclercq, B., & Nitenberg, G. (2001) · EMC - Anestesia-Reanimación · doi:10.1016/s1280-4703(01)71809-9
Cattel, F., Ancona, F., Chiumente, M., Miliacca, A., Motta, I., & Rosa, F. G. D. (2014) · European Journal of Hospital Pharmacy · doi:10.1136/ejhpharm-2013-000408
Börekçi, G., Ersöz, G., GÖKSU, M., Erdoğan, S., & Emekdaş, G. (2010) · Turkiye Klinikleri Journal of Medical Sciences · doi:10.5336/medsci.2009-14236
Untersuchungen an Flavonsäurederivaten mit hoher ß-Glukanaffinität
Torp-Patragst, B. (2003) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-2175
Mortality related to neonatal and pediatric fungal infections
Manzoni, P., & Castagnola, E. (2013) · Reviews in Health Care · doi:10.7175/rhc.v4i1s.857
“Per il paziente oncoematologico, quindi quello più a rischio, secondo dati storici [10-17], la mortalità è più bassa rispetto a quella dell’adulto, globalmente, forse perché i bambini sono “macchine nuove” e quindi resistono di più agli insulti dei farmaci che vengono loro somministrati o perché ricevono terapie compl…”
Emerging Candida spp. Infections
Georgiev, V. S. (2003) · Humana Press eBooks · doi:10.1007/978-1-59259-296-8_21
Kahl, D. (2015) · eDiss (Georg-August-Universität Göttingen) · doi:10.53846/goediss-5241
Adida, H. (2016) · Dépôt Institutionnel de lUniversité de Tlemcen
Desenvolupament experimental de nous tractaments antifúngics per a infeccions causades per llevats
Mestres, M. M. (2012) · Publicacions URV eBooks · doi:10.17345/9788469539231
Infections fongiques sévères en réanimation
Lerolle, N., Parize, P., & Lortholary, O. (2013) · Références en réanimation · doi:10.1007/978-2-8178-0389-0_17
Aquino, V. R. (2005) · Lume (Universidade Federal do Rio Grande do Sul)
Candida Infection in Intensive Care Unit Patients at Tertiary Care Hospital
Barot, N., Vegad, M. M., Soni, S. T., Sharma, K., & Shah, K. H. (2015) · Healthline
Invasive Candidiasis in Management of Infections in Cancer Patients
Bassetti, M., Mikulska, M., Gea‐Banacloche, J., & Viscoli, C. (2011) · Humana Press eBooks · doi:10.1007/978-1-60761-644-3_24
“infections [19]. Moreover, there has also been an increase in bloodstream infections due to nonalbicans species of Candida [12, 13, 20 ], surpassing C. albicans in some series [2, 3]. Candida glabrata, Candida parapsilosis, Candida tropicalis, and Candida krusei seem to be more common in immunocompromised patients [12…”
BackgroundSelf-citationHohes Risiko: Systemmykosen bei hämatologischen Patienten
Ruhnke, M. (2003) · Der Klinikarzt · doi:10.1055/s-2003-37792
TBHEB 2016-1 Vol 73 Full Printed Journal
DUMAN, M. (2016) · Turkish Bulletin of Hygiene and Experimental Biology · doi:10.5505/turkhijyen.2016.02438
Desenvolupament experimental de nous tractaments antifúngics per infeccions causades per llevats
Mestres, M. M. (2010) · Rovira & Virgili repository
Immunomodulation in severe infections
Leentjens, J. (2016) · Radboud Repository (Radboud University)
Morales, J. P. G., Briones‐Claudett, K. H., Briones-Claudett, M. H., Jurado, V. V., Alberto Sánchez, H., & Cruz, C. C. (2007) · USFQ Digital Repository (Universidad San Francisco de Quito)
Vesicular lesions of the oral mucosa.
Robinson, H. B. (1967) · PubMed
Cohen, D. L. C. D. Y. (2008) · Réanimation · doi:10.1016/s1624-0693(08)74004-0
“[6] Viscoli C, Girmenia C, Marinus A et al.”
BackgroundPuig‐Asensio, M. (2016) · LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas)
Yeast Infections After Haematopoietic Stem Cell Transplantation
Trubiano, J. A., Chen, S. C.-A., & Slavin, M. A. (2016) · Springer eBooks · doi:10.1007/978-3-319-28797-3_37
Siikala, E. (2011) · Helda - University of Helsinki Institutional Repository
Metadata
- Authors
- Viscoli, C., Girmenia, C., Marinus, A., Collette, L., Martino, P., Vandercam, B., Doyen, C., Lebeau, B., Spence, D., Krcmery, V., De Pauw, B., Meunier, F., & the Invasive Fungal Infection Group of the EORTC
- Affiliations
- University of Genoa (IT)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 1999-05
- Volume
- 28
- Issue
- 5
- Pages
- 1071-1079
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2126536749
- Cited by
- 601
- References
- 29
- Citations by year
- 2026: 2 · 2025: 2 · 2024: 5 · 2023: 11 · 2022: 6 · 2021: 9 · 2020: 9 · 2019: 8 · 2018: 16 · 2017: 15 · 2016: 16 · 2015: 22 · 2014: 27 · 2013: 31 · 2012: 25
- FWCI
- 21.24
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Digital Access to Libraries (Université catholique de Louvain (UCL), l'Université de Namur (UNamur) and the Université Saint-Louis (USL-B)) (submittedVersion)
- Dépôt institutionnel de l'Université libre de Bruxelles (Université Libre de Bruxelles) (submittedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Oncology › Neutropenia and Cancer Infections
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Keywords
- candidemia, invasive fungal infections, cancer patients, Candida albicans, non-albicans Candida, Candida glabrata, solid tumors, hematologic malignancies, acute leukemia, neutropenia, antifungal prophylaxis, allogeneic bone marrow transplantation, septic shock, 30-day mortality, risk factors
- MeSH terms
- Adult, Aged, Aged, 80 and over, Candida albicans, Candidiasis, Child, Child, Preschool, Cross Infection, Female, Humans, Male, Middle Aged, Neoplasms, Neutropenia, Population Surveillance, Prospective Studies, Multivariate Analysis, Survival Analysis, Hematologic Neoplasms
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.